银屑病患者的糖代谢
本文系统综述了调查银屑病患者糖代谢参数的临床研究,检索PubMed和Embase数据库,纳入26项报告胰岛素抵抗、糖耐量或胰岛素分泌且有相关对照组的临床研究。结果显示各研究结果存在广泛冲突,不足半数研究提示银屑病患者存在糖代谢缺陷,现有文献不能明确支持银屑病与2型糖尿病具有共同病理生理基础。
要点
- 26项临床研究结果广泛冲突,不足半数提示银屑病患者存在糖代谢缺陷
- 研究普遍缺乏关于可能混杂因素和患者特征的信息
- 研究方法各异,除一项研究外可能均不适合检测早期和细微的糖代谢缺陷
核心结论
- 现有文献不能明确支持银屑病与2型糖尿病具有共同病理生理基础。
- 需要设计良好的临床研究来揭示银屑病患者糖代谢中潜在的致糖尿病缺陷。
研究设计与样本
- 综述纳入调查银屑病患者糖代谢参数的临床研究,检索PubMed和Embase数据库,以成人银屑病患者糖代谢为主要或次要终点,要求纳入相关对照组。
- 共26项报告胰岛素抵抗、糖耐量或胰岛素分泌的临床研究符合纳入标准。
主要发现
- 各研究结果存在广泛冲突,不足半数研究显示结果提示银屑病患者存在糖代谢缺陷。
- 研究普遍缺乏关于可能混杂因素和患者特征的信息。
- 研究方法各异,除一项研究外,可能均不适合检测早期和细微的糖代谢缺陷。
局限性
- 研究普遍缺乏关于可能混杂因素和患者特征的信息。
- 研究方法各异,除一项研究外可能均不适合检测早期和细微的糖代谢缺陷。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epidemiological studies strongly suggest that psoriasis predisposes to type 2 diabetes. Several theories have been proposed to explain how these disease entities might be pathophysiologically connected. OBJECTIVES: Our primary objective was to elucidate whether clinical data support the notion of common pathophysiological denominators in patients with psoriasis and type 2 diabetes, and thus to delineate the association between the two conditions that has arisen on the basis of epidemiological studies. METHODS: We reviewed clinical studies investigating parameters of glucose metabolism in patients with psoriasis. The PubMed and Embase databases were searched for studies investigating glucose metabolism in adult patients with psoriasis as a primary or secondary end point. Studies had to include a relevant control group. RESULTS: Twenty-six clinical studies reporting on insulin resistance, glucose tolerance or insulin secretion were eligible for review. The results were widely conflicting, with less than half of the studies showing results suggestive of defective glucose metabolism in patients with psoriasis. In general, the studies suffered from a lack of information regarding possible confounders and patient characteristics. Furthermore, the research methods varied, and in all but one study they might not have been appropriate to detect early and subtle defects in glucose metabolism. CONCLUSIONS: The available literature does not unequivocally support common pathophysiological denominators in psoriasis and type 2 diabetes. Well-designed clinical studies are needed to expose potential diabetogenic defects in the glucose metabolism in patients with psoriasis.
引用
- Friis NU, Hoffmann N, Gyldenløve M, et al. Glucose metabolism in patients with psoriasis. Br J Dermatol. 2018. PMID: 30376181. doi:10.1111/bjd.17349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。